. only after drug failure
Speaker Kyoko Soejima
Congress : EHRA 2019
- Topic : arrhythmias and device therapy
- Sub-topic : Arrhythmias, General - Pathophysiology and Mechanisms
- Session type : Debate Session
- FP Number : 92
ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.